Skye Bioscience, Inc. (SKYE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 172.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -172.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 12.5M | 14.9M | 13.26M | 18.24M | 11.76M | 10.67M | 4.97M | 8.41M | 6.15M | 4.09M | 24.71M | 2.84M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.74M | 3.43M | 3.91M | 3.91M | 4.56M | 4.55M | 4.64M | 4.33M | 4.21M | 2.49M | 2.24M | 1.21M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.76M | 11.47M | 9.36M | 14.34M | 7.2M | 7.79M | 4.88M | 4.08M | 1.95M | 1.59M | 1.25M | 1.79M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | 0 | 0 | 0 | 1000K | -151.84K |
| Operating Income | -12.67M | -14.9M | -13.26M | -18.24M | -11.76M | -10.67M | -4.97M | -8.41M | -6.15M | -4.09M | -24.71M | -2.84M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -7.78% | -39.65% | -166.96% | -117.05% | -91.14% | -161.02% | 79.89% | -195.66% | -98.45% | 55.98% | -745.43% | 11.66% |
| EBITDA | -12.5M | -14.72M | -13.09M | -18.06M | -11.58M | -10.49M | -4.9M | -8.38M | -6.12M | -4.06M | -24.68M | -2.81M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -7.94% | -40.27% | -166.9% | -115.58% | -89.11% | -158.53% | 80.13% | -198.17% | -99.7% | 56.14% | -752.85% | 11.96% |
| D&A (Non-Cash Add-back) | 172.89K | 180.01K | 178.9K | 187.07K | 177.38K | 175.29K | 66K | 29.79K | 27.56K | 28.37K | 28.79K | 33.92K |
| EBIT | -12.67M | -14.44M | -12.75M | -17.62M | -11.1M | -9.79M | -3.61M | -7.44M | -4.58M | -4.09M | -24.65M | -2.92M |
| Net Interest Income | 167.42K | 274.1K | 0 | 533.09K | 617.6K | 732.27K | 1M | 511.19K | -10.42K | -379.83K | -254.75K | -177.83K |
| Interest Income | 169.62K | 274.1K | 0 | 533.09K | 619.05K | 732.27K | 1.29M | 961.24K | 426.51K | 50.3K | 16.56K | 8.6K |
| Interest Expense | 2.2K | 0 | 0 | 0 | 1.45K | - | 291.07K | 450.05K | 436.94K | 430.13K | 271.31K | 186.43K |
| Other Income/Expense | 165K | 453.58K | 509.87K | 622.45K | 658.24K | 919.62K | 1.07M | 510.83K | 1.13M | -333.67K | -240.07K | -264.9K |
| Pretax Income | -12.51M | -14.44M | -12.75M | -17.62M | -11.1M | -9.75M | -3.9M | -7.89M | -5.02M | -4.42M | -24.95M | -3.11M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 3.4K | 2K | 0 | 0 | 8.07K | 2K | 0 | 0 | 3.6K |
| Effective Tax Rate % | 0% | 0% | 0% | -0.02% | -0.02% | 0% | 0% | -0.1% | -0.04% | 0% | 0% | -0.12% |
| Net Income | -12.51M | -14.44M | -12.75M | -17.62M | -11.1M | -9.75M | -3.9M | -7.9M | -5.02M | -4.42M | -24.95M | -3.11M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -12.66% | -48.18% | -227.19% | -123.02% | -121.2% | -120.51% | 84.37% | -153.99% | 2.86% | 55.32% | -697.68% | 9% |
| Net Income (Continuing) | -12.51M | -14.44M | -12.75M | -17.62M | -11.1M | -9.75M | -3.9M | -7.9M | -5.02M | -4.42M | -24.95M | -3.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.32 | -0.36 | -0.32 | -0.44 | -0.28 | -0.24 | -0.10 | -0.20 | -0.18 | -0.36 | -3.17 | -0.80 |
| EPS Growth % | -14.29% | -50% | -220% | -120% | -55.56% | 33.33% | 96.85% | 75% | 86.86% | 92.79% | -100.63% | 68% |
| EPS (Basic) | -0.32 | -0.36 | -0.32 | -0.44 | -0.28 | -0.24 | -0.10 | -0.20 | -0.18 | -0.36 | -3.17 | -0.80 |
| Diluted Shares Outstanding | 39.68M | 39.66M | 39.67M | 39.66M | 39.65M | 39.97M | 38.82M | 38.67M | 28M | 12.35M | 7.88M | 3.89M |
| Basic Shares Outstanding | 39.68M | 39.66M | 39.67M | 39.66M | 39.65M | 39.97M | 38.82M | 38.67M | 28M | 12.35M | 7.88M | 3.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |